Company law change could cost pharma firms millions

• Companies say they will need regulatory approval in dozens of countries if forced to alter leaflets • Change could cause supply issues, businesses claim

2nd April, 2017

A minor change to Irish company law could result in higher global drug prices and cost tens of millions of euro, a number of major pharmaceutical companies have warned the government.

Several of the country’s biggest multinational employers are seeking an exemption to new rules requiring them to change the identifier at the end of their legal names. The drug companies have argued that should they be required to include descriptions such as ‘unlimited’, ‘limited’,...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Children prescribed adult doses of drugs at Kerry mental health centre

Health Róisín Burke 21 hours ago

Patients with rare diseases urge Dáil to pass law on orphan drugs

Health Daniel Murray 2 days ago

Contractor’s claims against children’s hospital could add €446m to project

Health Donal MacNamee 1 week ago

Spunout.ie to relaunch with new look